Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 1,386 results for "Business Crimes Bulletin"...

The Federal Prosecutor As Regulator
April 26, 2013
In the heavily regulated health care sector, the line between human error and a knowing "false claim" can be indistinct, aided and abetted by prosecutors' reliance on the FCA-defined concepts of "reckless disregard" and "deliberate ignorance" as proxies for proof of actual knowledge.
Business Crimes Hotline
March 28, 2013
A look at a recent notable ruling.
In the Courts
March 28, 2013
In-depth review of a key ruling.
Asset Forfeiture
March 28, 2013
Last month, the authors began discussion of the(DOJ's increased use of asset forfeiture and pursuit of higher-value forfeitures when it is prosecuting economic crimes. The discussion concludes herein.
Italy Adopts New Anti-Corruption Law
March 28, 2013
On Nov. 8, 2012, Italy enacted new anti-corruption legislation, joining other countries, including China, Russia and the United Kingdom, that have recently implemented strong anti-corruption measures.
Reducing Adverse Legal Consequences Through FCPA Remediation
March 28, 2013
In last month's issue, the authors observed that the DOJ and SEC have placed what they term a "high premium" on remediation efforts made by companies that discover or are accused of violations of the FCPA. The discussion concludes herein.
Business Crimes Hotline
February 27, 2013
A look at a recent case in which the DOJ leveraged FIRREA.
In the Courts
February 27, 2013
In-depth analysis of a recent key ruling.
Defending Against Asset Forfeiture
February 27, 2013
Given the DOJ's aggressive use of asset forfeitures, including higher-value forfeitures, counsel should be prepared to seek <i>Monsanto</i> hearings.
Navigating Turbulent FCPA Waters
February 27, 2013
While there have been high-profile setbacks to be sure, there is little reason to expect FCPA enforcement actions ' characterized by some as a tool in the war on terror ' to decline.

MOST POPULAR STORIES

  • Surveys in Patent Infringement Litigation: The Next Frontier
    Most experienced intellectual property attorneys understand the significant role surveys play in trademark infringement and other Lanham Act cases, but relatively few are likely to have considered the use of such research in patent infringement matters. That could soon change in light of the recent admission of a survey into evidence in <i>Applera Corporation, et al. v. MJ Research, Inc., et al.</i>, No. 3:98cv1201 (D. Conn. Aug. 26, 2005). The survey evidence, which showed that 96% of the defendant's customers used its products to perform a patented process, was admitted as evidence in support of a claim of inducement to infringe. The court admitted the survey into evidence over various objections by the defendant, who had argued that the inducement claim could not be proven without the survey.
    Read More ›
  • In the Spotlight
    On May 9, 2003, the U.S. Attorney's Office for the District of Massachusetts announced that Bayer Corporation, the pharmaceutical manufacturer, had been sentenced and ordered to pay a criminal fine of $5,590,800 stemming from its earlier plea of guilty to violating the Federal Prescription Drug Marketing Act by failing to list with the FDA its drug product, Cipro, that was privately labeled for an HMO. Such listing is required under the federal Food, Drug &amp; Cosmetic Act. The Federal Prescription Drug Marketing Act, Pub. L. 100-293, enacted on April 22, 1988, as modified on August 26, 1992 by the Prescription Drug Amendments (PDA) Pub. L. 102-353, 106 Stat. 941, amended sections 301, 303, 503, and 801 of the Federal Food, Drug, and Cosmetic Act, codified at 21 U.S.C. '' 331, 333, 353, 381, to establish requirements for distributing prescription drug samples.
    Read More ›